Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Medtronic
Johnson and Johnson
Merck
Moodys
Boehringer Ingelheim
AstraZeneca

Last Updated: May 19, 2022

MOXATAG Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard

Which patents cover Moxatag, and when can generic versions of Moxatag launch?

Moxatag is a drug marketed by Pragma and is included in one NDA. There are three patents protecting this drug.

This drug has eleven patent family members in six countries.

The generic ingredient in MOXATAG is amoxicillin. There are forty-six drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the amoxicillin profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Moxatag

A generic version of MOXATAG was approved as amoxicillin by TEVA on December 22nd, 1992.

  Try it Free

Summary for MOXATAG
Drug patent expirations by year for MOXATAG
Drug Prices for MOXATAG

See drug prices for MOXATAG

Recent Clinical Trials for MOXATAG

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Nationwide Children's HospitalN/A

See all MOXATAG clinical trials

US Patents and Regulatory Information for MOXATAG

MOXATAG is protected by three US patents.

Patents protecting MOXATAG

Pharmaceutical compositions and methods for improved bacterial eradication
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: USE OF ONCE-A-DAY AMOXICILLIN PRODUCT TO TREAT TONSILLITIS AND/OR PHARYNGITIS SECONDARY TO STREPTOCOCCUS PYOGENES

Compositions and methods for improved efficacy of penicillin-type antibiotics
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing

Modified release amoxicillin products
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: METHOD OF TREATING TONSILLITIS AND/OR PHARYNGITIS SECONDARY TO STREPTOCOCCUS PYOGENES IN A ONCE-A-DAY AMOXICILLIN PRODUCT

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pragma MOXATAG amoxicillin TABLET, EXTENDED RELEASE;ORAL 050813-001 Jan 23, 2008 DISCN Yes No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Pragma MOXATAG amoxicillin TABLET, EXTENDED RELEASE;ORAL 050813-001 Jan 23, 2008 DISCN Yes No See Plans and Pricing See Plans and Pricing Y Y See Plans and Pricing
Pragma MOXATAG amoxicillin TABLET, EXTENDED RELEASE;ORAL 050813-001 Jan 23, 2008 DISCN Yes No See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for MOXATAG

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pragma MOXATAG amoxicillin TABLET, EXTENDED RELEASE;ORAL 050813-001 Jan 23, 2008 See Plans and Pricing See Plans and Pricing
Pragma MOXATAG amoxicillin TABLET, EXTENDED RELEASE;ORAL 050813-001 Jan 23, 2008 See Plans and Pricing See Plans and Pricing
Pragma MOXATAG amoxicillin TABLET, EXTENDED RELEASE;ORAL 050813-001 Jan 23, 2008 See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for MOXATAG

See the table below for patents covering MOXATAG around the world.

Country Patent Number Title Estimated Expiration
Australia 2006321782 Pharmaceutical compositions and methods for improved bacterial eradication See Plans and Pricing
World Intellectual Property Organization (WIPO) 2007067770 See Plans and Pricing
European Patent Office 1542656 See Plans and Pricing
European Patent Office 1257255 See Plans and Pricing
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Harvard Business School
Dow
Express Scripts
Colorcon
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.